2
Preface Macrocycles are an exceptionally interesting structural class of small molecules with proven therapeutic value that have been the subject of medicinal chemistry research for many years. The increasing effort devoted to the design and synthesis of macrocyclic molecules in both academic and industrial drug discovery programmes, with exciting developments in understanding the determinants of properties such as potency, selectivity, permeability and bioavailability for these molecules, as well as advances in the synthetic methodologies that provide access to them, has provided the impetus for the construction of this volume. It is the goal of this book to bring together scientific experts, who have been directly involved in research to discover and develop drugs based on macrocyclic scaffolds, and afford them a forum to present the state of the art in their field including, in some cases, drugs with exciting potential that have advanced to clinical trials or to the market. It is my hope that the topics covered herein will provide essential background information on the genesis and evolution of macrocyclic compounds in drug discovery, as well as offering a sense of the promise of what this field may deliver in the future. I would like to express my great appreciation to each of the chapter authors for the time and effort spent to write informative reviews on their respective areas of research. I would also like to express my appreciation to Professor David Rotella (Montclair State University), and Rosalind Searle, Helen Prasad and Rowan Frame at the Royal Society of Chemistry for their help, support and patience in the course of putting together this book. Jeremy I. Levin RSC Drug Discovery Series No. 40 Macrocycles in Drug Discovery Edited by Jeremy Levin r The Royal Society of Chemistry 2015 Published by the Royal Society of Chemistry, www.rsc.org vii Downloaded on 08/10/2014 20:02:32. Published on 03 October 2014 on http://pubs.rsc.org | doi:10.1039/9781782623113-FP007

[RSC Drug Discovery] Macrocycles in Drug Discovery || Preface

  • Upload
    jeremy

  • View
    215

  • Download
    3

Embed Size (px)

Citation preview

Preface

Macrocycles are an exceptionally interesting structural class of smallmolecules with proven therapeutic value that have been the subject ofmedicinal chemistry research for many years. The increasing effort devotedto the design and synthesis of macrocyclic molecules in both academic andindustrial drug discovery programmes, with exciting developments inunderstanding the determinants of properties such as potency, selectivity,permeability and bioavailability for these molecules, as well as advances inthe synthetic methodologies that provide access to them, has provided theimpetus for the construction of this volume.

It is the goal of this book to bring together scientific experts, who havebeen directly involved in research to discover and develop drugs based onmacrocyclic scaffolds, and afford them a forum to present the state of the artin their field including, in some cases, drugs with exciting potential thathave advanced to clinical trials or to the market. It is my hope that the topicscovered herein will provide essential background information on the genesisand evolution of macrocyclic compounds in drug discovery, as well asoffering a sense of the promise of what this field may deliver in the future.

I would like to express my great appreciation to each of the chapterauthors for the time and effort spent to write informative reviews on theirrespective areas of research. I would also like to express my appreciation toProfessor David Rotella (Montclair State University), and Rosalind Searle,Helen Prasad and Rowan Frame at the Royal Society of Chemistry for theirhelp, support and patience in the course of putting together this book.

Jeremy I. Levin

RSC Drug Discovery Series No. 40Macrocycles in Drug DiscoveryEdited by Jeremy Levinr The Royal Society of Chemistry 2015Published by the Royal Society of Chemistry, www.rsc.org

vii

Dow

nloa

ded

on 0

8/10

/201

4 20

:02:

32.

Publ

ishe

d on

03

Oct

ober

201

4 on

http

://pu

bs.r

sc.o

rg |

doi:1

0.10

39/9

7817

8262

3113

-FP0

07

Dow

nloa

ded

on 0

8/10

/201

4 20

:02:

32.

Publ

ishe

d on

03

Oct

ober

201

4 on

http

://pu

bs.r

sc.o

rg |

doi:1

0.10

39/9

7817

8262

3113

-FP0

07View Online